A forum for original data, hematological innovation, and evidence-based knowledge of primary clinical relevance. Program covers every hematologic subspecialty and includes satellite symposia, Updates-in-Hematology, and an exhibition organized by pharmaceutical companies and national and international non-profits.
In view of the emergence of the COVID-19 virus as a worldwide threat, the International PNH Interest Group Board of Directors unanimously agreed today to postpone until the second quarter of 2021 the First IPIG International Workshop: Recent Advances in Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia.
This decision was not easily made, particularly after the Programme Committee developed a compelling agenda and engaged a distinguished faculty drawn from six continents. In the end, the virus’s rapid and unpredictable transmission, and the consequent impact on communities across the globe, including their respective health care systems and social structures, left us with no other responsible choice.
The Board also did not want to encourage workshop faculty or participants to travel at a time when travel has risks, and has in fact been banned in and out of some countries and regions. Without certainty that the virus will have run its course by the fourth quarter of 2020, the decision was consequently made to postpone the workshop for a year.
We are disappointed that circumstances beyond our control have led us to this decision, but are in agreement with healthcare providers who are witnessing the impacts of the disease on our individual medical centres, teaching institutions, and communities at large that it is the only responsible decision to make.
It is our plan to situate the 2021 conference in Harrogate, UK. As we move 2021 planning forward, we will post updates on the IPIG website and communicate with IPIG members by email. In the meantime, if you have any questions about the workshop, please contact us at email@example.com.